Immunology has increasingly taken a central place in modern biomedicine and has powerfully captured the popular imagination. From revolutionizing vaccine development during the COVID-19 pandemic to delivering deep insights into autoimmune diseases and cancer treatment, immunology research is driving biomedical innovation more now than ever. The recent pandemic has exposed immunology not as an esoteric branch of science, but as the foundation of public health, economic stability, and human resilience.
The field of immunology began to benefit humanity even before its mechanisms were fully understood. The classic example is undeniable: Edward Jenner’s insights led to the invention of vaccines in 1796, more than two centuries before immunology was formalized as a specialized field. The significant number of Nobel Prizes in Physiology or Medicine awarded to immunologists underlines the crucial importance of this field. Looking to the future, strategically developing expertise in immunology, especially in populous countries like India with unique healthcare challenges, will be critical to addressing global health threats and advancing personalized medicine.
Crucial role
The consistent recognition of immunological discoveries by the Nobel Foundation highlights the transformative impact of the field. In total, immunology has been honored with Nobel Prizes in 16 different years, with 31 laureates. In the past fifty years alone, 21 immunologists have received the prize. This pattern illustrates how the accumulation of knowledge and technological advances in immunology has transformed our understanding of human health and disease over the past half century.
The latest addition to this distinguished legacy is the 2025 Prize awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their discoveries in the field of peripheral immune tolerance. Their joint work identified regulatory T cells, revealing the body’s advanced mechanism for preventing autoimmune attacks. These “guardians” of the immune system maintain balance by suppressing overactive immune responses, a discovery that has opened new avenues for treating autoimmune diseases, cancer and transplant rejection. The 2025 Prize celebrates specific breakthroughs and highlights the continued central role of immunology in biomedical progress.
The COVID-19 pandemic has also demonstrated the critical role of immunology in global health. The record-breaking development of effective vaccines against SARS-CoV-2 was made possible by decades of fundamental immunological research, especially in the field of mRNA vaccine technology (awarded a Nobel Prize in 2023). The pandemic accelerated the adoption of new vaccine platforms and highlighted their potential for addressing future health crises. The response illustrated how immunological knowledge, when effectively translated into technologies, can change the course of global events and underscored the need to maintain robust research ecosystems in preparation for future infectious disease threats.
Expanding the scope
Immunology has also fundamentally transformed cancer treatment through immunotherapies that harness the immune system to recognize and eliminate tumor cells. Checkpoint inhibitors (Nobel Prize 2018), CAR T cell therapies and cancer vaccines now represent a new pillar of oncology that complements traditional modalities such as chemotherapy and radiation.
The scope of immune-based therapies is expanding into clinical contexts once separate from immunology. Scientists are exploring the link between the immune system and the brain and how inflammation may contribute to depression and neurodegenerative diseases. In fact, there is mounting evidence that the immune system plays a role in metabolic disorders and aging, creating the opportunity for immunomodulatory therapies for conditions like diabetes and to promote healthier, longer lives.
The immune system, it turns out, is not just a shield against germs: it is a master regulatory network, intimately linked to the function of every organ and every biological process.
Thus, the strategic importance of immunology in the future of biomedicine cannot be overstated. From Nobel Prize-winning basic research to revolutionary clinical applications, immunological knowledge remains the driving force behind medical progress. For a country like India, with its enormous population and unique burden of communicable and non-communicable diseases, the immunological revolution presents both a monumental opportunity and a significant challenge. By addressing current weaknesses in training programs and leveraging unique population resources, India can position itself as a leader in immunology research relevant to both local and global health priorities. Nurturing this field through education, research investments and international collaboration will be essential to realizing its full potential to improve human health worldwide.
Investing in immunology
The strength of Indian medicine has traditionally been its clinical acumen and ability to treat large numbers of patients. However, to truly participate in and benefit from the coming era of immunomedicine, a robust foundation in immunology education is not a luxury: it is an urgent necessity. We must therefore fundamentally reform the way we teach and practice immunology, and foster stronger collaborations between basic immunologists in laboratories and physicians on the front lines of hospitals. This also requires a reinterpretation of immunological pedagogy in basic biology. Due emphasis should be placed on immunology in undergraduate and postgraduate curricula, not only to keep pace with scientific progress but also to keep students abreast of technological innovations in this field.
Reforms to better prepare our biologists and medical professionals for the future will also encourage homegrown research tailored to India’s specific needs. Can we design vaccines that are uniquely effective for our population? Why are certain autoimmune diseases more common or present differently here? How can we develop more affordable versions of advanced immunotherapies for Indian cancer patients? The answers to these questions may not come from abroad; they must be cultivated in our own institutions.
Looking ahead, the countries that lead the way in biomedicine will be those that have invested not only in research infrastructure, but also in their human capital: training a generation of scientists, physicians and technologists fluent in the complex language of immunology.
For India, embracing this ‘immunology era’ is critical to transforming its healthcare system from a major provider of essential care to a global leader in the next wave of medical innovation, ensuring that the wonders of modern immunology reach all its citizens.
Dipyaman Ganguly is Professor and Head of the Department of Biology, Ashoka University, Sonipat.
Published – Oct 20, 2025 05:30 IST
#future #India #medicine #means #embracing #immunology #today